LMDX

LumiraDx Limited

0.11 USD

Last updated Nov 29, 07:54 UTC

Yesterday HIGH

$0.12

Yesterday LOW

$0.11

52w HIGH

$1.49

52w LOW

$0.08

EPS

-0.16

PE

-0.69

Next Earnings

Dec 12, 2023

Overview News Government Trades

LumiraDx Limited stock is up 22.11% since 30 days ago. The next earnings date is Dec 12, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 November’s closed higher than October.

LumiraDx focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. Its testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

lumiradx.com

Benzinga Insights

Tue Oct 24, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Lisa Levin

Tue Oct 24, 2023

Why Logitech International Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares surged 91.2% to $0.2180 in pre-market trading after falling 10% on Monday.
Benzinga Insights

Mon Oct 23, 2023

12 Health Care Stocks Moving In Monday's After-Market Session
Lisa Levin

Mon Oct 23, 2023

Crude Oil Falls Sharply; Apollomics Shares Plunge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded down 0.19% to 33,062.85 while the NASDAQ rose 0.80% to 13,088.09. The S&P 500 also rose, gaining, 0.28% to 4,236.12.
Lisa Levin

Mon Oct 23, 2023

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
Benzinga Insights

Mon Oct 23, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Lisa Levin

Mon Oct 23, 2023

Nasdaq Turns Higher; Akumin Shares Jump

U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday. The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500 also rose, gaining, 0.29% to 4,236.55.
Lisa Levin

Mon Oct 23, 2023

Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell 0.33% to 12,940.56. The S&P 500 also fell, dropping, 0.33% to 4,210.14.
Benzinga Insights

Mon Oct 23, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
ryanfaloona@benzinga.com

Mon Oct 23, 2023

Market-Moving News for October 23rd

LMDX: 387% | LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England's First Heart & Lung Screening Hub APLM: 34% | Apollomics Announces Efficacy of Vebreltinib in